Delivery formulations

Helen Harrington’s journey: Patience, passion, and problem-solving

20-Nov-2024 By Liza Laws

From developing treatments for Ebola to mastering karate with her daughters, Dr. Helen Harrington’s journey is one of resilience and curiosity.

Overcoming nonspecific binding challenges in pharmacokinetic assays

14-Nov-2024 By Liza Laws

Pharmacokinetic (PK) tests form an integral part of the drug development process, helping to ensure the safety and efficacy of new drugs.

Competitors race to launch GLP-1 drugs amid soaring weight loss demand

31-Oct-2024 By Clara Rodriguez Fernandez

Demand for weight loss drugs targeting GLP-1 has exploded in recent years, leading to disruptions in supply chains. Here are the companies racing for approval of their own versions of these highly coveted drugs.

Drug discovery and bringing new medicine to market - the future of AI in pharma

08-Oct-2024 By Liza Laws

Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a value of $22.6 billion dollars by next year (2025).

CPHI 2024: Stevanato to unveil large-volume injectable platform

02-Oct-2024 By Liza Laws

The company, a provider of drug containment and delivery solutions, will introduce its expanded Vertiva 10mL on-body delivery system.

Ardena debuts new nanomedicines facility at CPHI 2024

02-Oct-2024 By Liza Laws

At CPHI Milan 2024, Ardena will showcase its latest advancements in drug development and manufacturing, including the launch of a state-of-the-art nanomedicines GMP facility in Oss, Netherlands.

CPHI 2024

CBD-based formulations from dsm-firmenich at CPHI 2024

02-Oct-2024 By Liza Laws

At this October’s CPHI event being held in Milan, dsm-firmenich, is inviting stakeholders across the pharmaceutical market to immerse themselves in its patient-inspired innovations.

Innovative approaches to opioid use disorder treatment

12-Sep-2024 By Liza Laws

As local and state governments in the US begin to receive and distribute their opioid settlement funds, Sonara Health has developed a comprehensive report analyzing how over $50 billion in national funds can be effectively allocated to address the opioid...

Breaking barriers in science: Thermo Fisher's Melanie Adams-Cioaba on innovation and inclusion

22-Aug-2024 By Liza Laws

In the rapidly evolving field of drug discovery, Melanie Adams-Cioaba stands at the forefront, leading transformative advancements in cryo-electron microscopy (cryo-EM) at Thermo Fisher Scientific.

Lonza boosts clinical services with new bottling capabilities

15-Aug-2024 By Liza Laws

Lonza, a global leader in the pharmaceutical, biotech, and nutraceutical markets, has announced a significant expansion of its clinical manufacturing services at its small molecules site in Bend, Oregon.

FDA approves Rusan Pharma’s manufacturing facility in India, paving the way for expanded US presence

23-Jul-2024 By Liza Laws

Rusan Pharma Private Limited has announced that its active pharmaceutical ingredient (API) manufacturing facility in Ankleshwar, Gujarat, has been granted Good Manufacturing Practice (GMP) approval by the FDA.

Apollo Therapeutics and University of Oxford collaborate to revolutionize drug development

22-Jul-2024 By Liza Laws

Apollo Therapeutics and the University of Oxford have embarked on a collaborative journey in drug discovery and development.

Roche’s oral GLP-1 receptor agonist shows promising early weight loss results in phase 1

18-Jul-2024 By Helen Albert

Roche’s recent $2.7 billion acquisition of Carmot Therapeutics is paying off, with positive results for new oral GLP-1 receptor agonist.

Nipro's $397.8M investment brings 232 new jobs to Greenville, NC with exciting new facility

18-Jul-2024 By Liza Laws

Japanese medical devices company, Nipro Medical Corporation, a giant in the healthcare and medical device industry, has announced a major investment of $397.8 million to establish its first North American manufacturing center of excellence in Greenville,...

Could this be the end of condoms and will men embrace the hormone-free birth control pill?

11-Jul-2024 By Liza Laws

In an exclusive interview, Akash Bakshi, CEO of YourChoice Therapeutics, delves into the inspiration and journey behind developing a hormone-free birth control pill for men.

dsm-firmenich launches CBtru, revolutionizing CBD drug development with enhanced bioavailability

09-Jul-2024 By Liza Laws

dsm-firmenich has announced the launch of CBtru – an advanced formulated cannabidiol (CBD) drug product intermediate designed for oral solid delivery formats.

Esteve invests €100 million in Spanish API manufacturing muscle

02-Jul-2024 By Jonathan Smith

The Spanish company Esteve Pharmaceuticals is building a manufacturing unit in its Girona plant with the aim to expand its production of active pharmaceutical ingredients (APIs).

Is Combogesic IV revolutionizing pain management in the US healthcare market?

11-Jun-2024 By Liza Laws

Hikma Pharmaceuticals PLC has made a significant announcement, marking the US launch of Combogesic IV, an intravenous, opioid-free pain relief medication providing a multimodal approach to managing pain in adults.

Sonara Health: Transforming methadone treatment access for opioid use disorder patients

10-Jun-2024 By Liza Laws

In an inspiring conversation with Liza Laws, Dr. Michael Giles, MD, and chief executive officer of Sonara Health, shares the innovative journey of creating a platform to enhance the accessibility of methadone treatment for opioid use disorder patients.

Roquette solving toughest drug development challenges with new capsules

14-May-2024 By Liza Laws

Roquette, a global leader in plant-based ingredients and a key provider of pharmaceutical and nutraceutical excipients, announced today (May 14) the launch of its innovative Lycagel Flex hydroxypropyl pea starch premix for softgel capsules.

PCI Pharma initiates installation of $100M isolator-based sterile fill-finish site

07-May-2024 By Liza Laws

PCI Pharma Services, a global leader in contract development and manufacturing, has embarked on the installation of crucial equipment for its latest sterile fill-finish facility at its Bedford, NH campus in Philadelphia.

Lonza integrates advanced technology to simplify synthetic route identification for novel APIs

30-Apr-2024 By Liza Laws

Yesterday (April 29), Lonza, a global partner in the pharmaceutical, biotech, and nutraceutical sectors, announced the introduction of its AI-enabled Route Scouting Service (RSS).

Unlocking Synergies: LGM Pharma's strategic approach to sourcing and growth in India

26-Apr-2024 By Liza Laws

In an extensive and enlightening chat with Prasad Raje, the CEO of LGM Pharma, OSP gained profound insights into the company's trajectory within the pharmaceutical industry.

Catching up with LGM Pharma ahead of CPhI North America to find out about its pipeline

19-Apr-2024 By Liza Laws

LGM Pharma is a leading CDMO provider of comprehensive API sourcing and drug product contract development and manufacturing solutions to the pharmaceutical, biotechnology, and compounding pharmacy industries.

Production of tree-saving transformative vaccine adjuvant with in-lab plants

17-Apr-2024 By Liza Laws

During DCAT this year, CEO Gaston Salinas from Botanical Solution Inc., (BSI), sat down with Liza Laws, the senior editor of OSP and BPR to discuss his company’s pioneering work in revolutionizing vaccine adjuvant production.

DCAT

DCAT Debrief: Lonza's perspective on pharma's path forward with AI and drug development

16-Apr-2024 By Liza Laws

In a recent discussion with Jan Vertommen, vice president and head of commercial development for the small molecules division at Lonza, key insights were shared regarding the pharmaceutical industry's current landscape and future trajectory.

Adragos Pharma - poised to make a lasting impact in the pharmaceutical industry

11-Apr-2024 By Liza Laws

Adragos Pharma is a contract development and manufacturing organization (CDMO) that provides development and manufacturing services for drug products. It concentrates on small molecule dosage forms including sterile and non-sterile liquids, solids, and...

Pluss unveils Celsure XL VIP pallets - a game-changer for the pharma industry?

03-Apr-2024 By Liza Laws

Pluss, a leading provider of temperature-controlled packaging solutions, today (April 3) launched its latest innovation, the Celsure XL VIP pallets.

Drug discovery and global player, Cresset, moves team into Boston marking major turning point

12-Mar-2024 By Liza Laws

Greater integration is to take place between the US and UK following an expansion says Cresset, a provider of integrated in-silico solutions for drug discovery.

Webinar: Innovations in drug delivery - tune in and join our excellent panel

27-Feb-2024 By Liza Laws

As the landscape of healthcare continues to evolve, so too does the field of drug delivery.

AstraZeneca’s Tagrisso that delays lung disease progression by nine months gets FDA approval

19-Feb-2024 By Liza Laws

Patients in the US with epidermal growth factor receptor mutated (EGFRm) advanced lung cancer can now receive an important new treatment option delaying disease progression by nearly nine additional months.

dsm-firmenich and Zerion Pharma partnership will focus on patient centric CBD formulations

15-Feb-2024 By Liza Laws

dsm-firmenich, today (February 15) announces its exclusive partnership with Zerion Pharma A/S to unlock a new era in cannabinoid innovation that champions patient-centric formulations.

Startup founded to help an 'NHS in crisis' by creating digital clinics accessed as easily as online banking

01-Feb-2024 By Liza Laws

A husband-and-wife team keen to find a solution to an ‘NHS in crisis’ have secured $1.5 million in seed funding for their UK-based startup providing AI-powered clinical and drug prescription services for minor conditions.

Stevanato Group tackling flexible drug containment packages and filling solutions

30-Jan-2024 By Liza Laws

Two new offerings have been unveiled by drug delivery and solutions provider, Stevanto Group S.p.A.

Aversa Fentanyl combines abuse-deterrent transdermal technology with fentanyl patch system

15-Jan-2024 By Liza Laws

Access to opioids such as fentanyl can lead to abuse but now two companies have signed an agreement to reduce the abuse potential while making sure they are still accessible to those who need them.

Cormica Bradford expanding equipment range to update capabilities

15-Jan-2024 By Liza Laws

Cormica Bradford, a division of Cormica says it is proud to announce a significant expansion of its laboratory capabilities.

Roquette and Qualicaps combine to expand global footprint

08-Dec-2023 By Liza Laws

Pharma and plant-based ingredient giant, Roquette, has confirmed its acquisition of Qualicaps from the Mitsubishu Chemical Group.

Symbiosis Pharmaceutical Services granted MHRA license following £1 million investment

07-Dec-2023 By Liza Laws

Symbiosis Pharmaceutical Services can now test small molecule, biological and advanced therapeutical medicinal products (ATMP) following a £1 million investment.

Piramal Pharma has launched a high-throughput screening facility

06-Dec-2023 By Liza Laws

Piramal Pharma has launched a high-throughput screening facility at its drug discovery services site in Ahmedabad, India.

Lilly's plans for $2.5 billion site in Germany to expand injectable manufacturing capacity

06-Dec-2023 By Liza Laws

Eli Lilly has invested in its manufacturing capacity once more and has announced plans to build a $2.5 billion high-tech manufacturing site in Germany.

CellCentric's new ways to treat specific blood cancers published in Cancer Cell journal

22-Nov-2023 By Liza Laws

A cornerstone paper published in peer-reviewed scientific journal, Cancer Cell, has demonstrated a new way to treat specific blood cancers.

Pfizer's first acute migraine treatment recommended by NICE

28-Sep-2023 By Liza Laws

The first treatment for acute migraine made by Pfizer Ltd has been recommended by the National Institute for Health and Care Excellence (NICE).

GSK’s Ojjaara approved by FDA for patients with blood cancer and anemia

18-Sep-2023 By Jonathan Smith

The small molecule drug Ojjaara (momelotinib), developed by GlaxoSmithKline, has become the first U.S. Food and Drug Administration (FDA)-approved treatment for patients with the blood cancer myelofibrosis and anemia.

Calliditas Therapeutics advances kidney disease drug, meeting primary endpoint in study

15-Aug-2023 By Liza Laws

Calliditas Therapeutics AB’s phase 3 study looking at a cure for a kidney disease called IgA nephropathy (IgAN) has met its primary endpoint and the full data has been published in The Lancet.

Citius reaches 92 milestone events in phase 3 catheter-related bloodstream infections trial

14-Aug-2023 By Liza Laws

Patients suffering from catheter-related bloodstream infections could be treated with Citius Pharmaceuticals antibiotic lock solution after it achieved 92 milestone events in its phase 3 trial.

Soft mist inhaler for PAH result of joint venture between Thaerapy and Resyca

19-Jun-2023 By Liza Laws

A soft mist inhaler made by Resyca BV, a joint venture of Medspray Pharma BV and Recipharm AB, is being brought to patients with pulmonary arterial hypertension (PAH).